Literature DB >> 17622304

Transcription factors in muscle atrophy caused by blocked neuromuscular transmission and muscle unloading in rats.

Jenny Nordquist1, Anna-Stina Höglund, Holly Norman, Xiaorui Tang, Barry Dworkin, Lars Larsson.   

Abstract

The muscle wasting associated with long-term intensive care unit (ICU) treatment has a negative effect on muscle function resulting in prolonged periods of rehabilitation and a decreased quality of life. To identify mechanisms behind this form of muscle wasting, we have used a rat model designed to mimic the conditions in an ICU. Rats were pharmacologically paralyzed with a postsynaptic blocker of neuromuscular transmission, and mechanically ventilated for one to two weeks, thereby unloading the limb muscles. Transcription factors were analyzed for cellular localization and nuclear concentration in the fast-twitch muscle extensor digitorum longus (EDL) and in the slow-twitch soleus. Significant muscle wasting and upregulation of mRNA for the ubiquitin ligases MAFbx and MuRF1 followed the treatment. The IkappaB family-member Bcl-3 displayed a concomitant decrease in concentration, suggesting altered kappaB controlled gene expression, although NFkappaB p65 was not significantly affected. The nuclear levels of the glucocorticoid receptor (GR) and the thyroid receptor alpha1 (TRalpha1) were altered and also suggested as potential mediators of the MAFbx- and MuRF1-induction in the absence of induced Foxo1. We believe that this model, and the strategy of quantifying nuclear proteins, will provide a valuable tool for further, more detailed, analyses of the muscle wasting occurring in patients kept on a mechanical ventilator.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622304      PMCID: PMC2014727          DOI: 10.2119/2006-00066.Nordquist

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  48 in total

1.  NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching.

Authors:  Karl J A McCullagh; Elisa Calabria; Giorgia Pallafacchina; Stefano Ciciliot; Antonio L Serrano; Carla Argentini; John M Kalhovde; Terje Lømo; Stefano Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-09       Impact factor: 11.205

Review 2.  NF-kappaB: a multifaceted transcription factor regulated at several levels.

Authors:  M Lienhard Schmitz; Ivan Mattioli; Holger Buss; Michael Kracht
Journal:  Chembiochem       Date:  2004-10-04       Impact factor: 3.164

3.  Effects of denervation on enzyme-histochemical and morphometrical properties of the rat soleus muscle in relation to age.

Authors:  T Ansved; L Larsson
Journal:  Acta Physiol Scand       Date:  1990-06

4.  Three slow myosin heavy chains sequentially expressed in developing mammalian skeletal muscle.

Authors:  S M Hughes; M Cho; I Karsch-Mizrachi; M Travis; L Silberstein; L A Leinwand; H M Blau
Journal:  Dev Biol       Date:  1993-07       Impact factor: 3.582

5.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

6.  IKKbeta/NF-kappaB activation causes severe muscle wasting in mice.

Authors:  Dongsheng Cai; J Daniel Frantz; Nicholas E Tawa; Peter A Melendez; Byung-Chul Oh; Hart G W Lidov; Per-Olof Hasselgren; Walter R Frontera; Jongsoon Lee; David J Glass; Steven E Shoelson
Journal:  Cell       Date:  2004-10-15       Impact factor: 41.582

Review 7.  Expanded nuclear roles for IkappaBs.

Authors:  Paul W Bates; Shigeki Miyamoto
Journal:  Sci STKE       Date:  2004-10-12

8.  CaM kinase II-dependent phosphorylation of myogenin contributes to activity-dependent suppression of nAChR gene expression in developing rat myotubes.

Authors:  Huibin Tang; Peter Macpherson; Lawrence S Argetsinger; Danuta Cieslak; Steven T Suhr; Christin Carter-Su; Daniel Goldman
Journal:  Cell Signal       Date:  2004-05       Impact factor: 4.315

9.  The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors.

Authors:  Trevor N Stitt; Doreen Drujan; Brian A Clarke; Frank Panaro; Yekatarina Timofeyva; William O Kline; Michael Gonzalez; George D Yancopoulos; David J Glass
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

Review 10.  Calcineurin and skeletal muscle growth.

Authors:  Robin N Michel; Shannon E Dunn; Eva R Chin
Journal:  Proc Nutr Soc       Date:  2004-05       Impact factor: 6.297

View more
  16 in total

Review 1.  The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?

Authors:  T van Wessel; A de Haan; W J van der Laarse; R T Jaspers
Journal:  Eur J Appl Physiol       Date:  2010-07-03       Impact factor: 3.078

2.  Myotube formation on micro-patterned glass: intracellular organization and protein distribution in C2C12 skeletal muscle cells.

Authors:  Daniel L Yamamoto; Robert I Csikasz; Yu Li; Gunjana Sharma; Klas Hjort; Roger Karlsson; Tore Bengtsson
Journal:  J Histochem Cytochem       Date:  2008-06-23       Impact factor: 2.479

3.  Sparing of muscle mass and function by passive loading in an experimental intensive care unit model.

Authors:  Guillaume Renaud; Monica Llano-Diez; Barbara Ravara; Luisa Gorza; Han-Zhong Feng; Jian-Ping Jin; Nicola Cacciani; Ann-Marie Gustafson; Julien Ochala; Rebeca Corpeno; Meishan Li; Yvette Hedström; G Charles Ford; K Sreekumaran Nair; Lars Larsson
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

Review 4.  Skeletal muscle atrophy: disease-induced mechanisms may mask disuse atrophy.

Authors:  C J Malavaki; G K Sakkas; G I Mitrou; A Kalyva; I Stefanidis; K H Myburgh; C Karatzaferi
Journal:  J Muscle Res Cell Motil       Date:  2016-01-04       Impact factor: 2.698

Review 5.  The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy.

Authors:  Victoria C Foletta; Lloyd J White; Amy E Larsen; Bertrand Léger; Aaron P Russell
Journal:  Pflugers Arch       Date:  2011-01-11       Impact factor: 3.657

Review 6.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

7.  Preferential skeletal muscle myosin loss in response to mechanical silencing in a novel rat intensive care unit model: underlying mechanisms.

Authors:  Julien Ochala; Ann-Marie Gustafson; Monica Llano Diez; Guillaume Renaud; Meishan Li; Sudhakar Aare; Rizwan Qaisar; Varuna C Banduseela; Yvette Hedström; Xiaorui Tang; Barry Dworkin; G Charles Ford; K Sreekumaran Nair; Sue Perera; Mathias Gautel; Lars Larsson
Journal:  J Physiol       Date:  2011-02-14       Impact factor: 5.182

Review 8.  Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1.

Authors:  Sue C Bodine; Leslie M Baehr
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-08-05       Impact factor: 4.310

9.  Myofibrillar protein and gene expression in acute quadriplegic myopathy.

Authors:  Holly Norman; Håkan Zackrisson; Yvette Hedström; Per Andersson; Jenny Nordquist; Lars I Eriksson; Rolf Libelius; Lars Larsson
Journal:  J Neurol Sci       Date:  2009-06-06       Impact factor: 3.181

10.  Identification of a KLF5-dependent program and drug development for skeletal muscle atrophy.

Authors:  Lin Liu; Hiroyuki Koike; Takehito Ono; Shinichiro Hayashi; Fujimi Kudo; Atsushi Kaneda; Hiroyuki Kagechika; Ichiro Manabe; Tomoki Nakashima; Yumiko Oishi
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-31       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.